Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jack Holladay

Bellaire, TX Medical Doctor

NPI 1851321277 CMS profile 356152

6802 Mapleridge St, 200, Bellaire, TX 77401

Open in the dashboard

General payments

$1,184,614

125 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$347,173

4 holdings reported · through program year 2025

Through program year 2025, Jack Holladay of Bellaire, TX is reported in the CMS Open Payments database as having received $1,184,614 across 125 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $347,173 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $108,266 15
2024 General $37,140 13
2023 General $276,333 17
2022 General $273,130 17
2021 General $198,010 17
2020 General $75,810 17
2019 General $215,925 29
2022 Ownership $122,646 1
2021 Ownership $126,527 2
2020 Ownership $98,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jack Holladay
  • Texas median
  • Middle half of Texas
  • National median

In program year 2025, general payments to Jack Holladay were reported at $108,266. Among 86,592 Texas profiles paid that year, the median was $188 and the middle half received between $55 and $669.

Show as a table
Year Jack Holladay Texas median Middle half National median
2019 $215,925 $191 $56–$744 $163
2020 $75,810 $125 $38–$452 $114
2021 $198,010 $150 $43–$543 $132
2022 $273,130 $169 $50–$606 $149
2023 $276,333 $183 $53–$639 $160
2024 $37,140 $188 $55–$666 $164
2025 $108,266 $188 $55–$669 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Carl Zeiss Meditec AG $658,460 13 payments
  2. OCULUS, Inc. $240,000 84 payments
  3. Carl Zeiss Meditec Digital Innovations LLC $103,675 8 payments
  4. RxSight Inc $81,509 2 payments
  5. Alcon Research LLC $33,250 4 payments
  6. Heidelberg Engineering, Inc. $27,720 7 payments
  7. Johnson & Johnson Surgical Vision, Inc. $25,000 1 payment
  8. Reliance Medical Products, Inc. $10,000 1 payment
  9. Bausch & Lomb, a division of Bausch Health US, LLC $3,000 3 payments
  10. Bausch & Lomb Americas Inc. $2,000 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $772,135 22 payments
  2. Consulting Fee $283,970 87 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $83,509 4 payments
  4. Honoraria $44,000 11 payments
  5. Education $1,000 1 payment
Products named General payments · program years 2019–2025
  1. IOLMaster 500 $524,350 3 payments
  2. Pentacam $120,000 48 payments
  3. IOLMaster 700 $112,675 12 payments
  4. VERACITY SURGICAL $98,400 4 payments
  5. OCULUS Pentacam $90,000 24 payments
  6. RXSIGHT LIGHT DELIVERY DEVICE (LDD) $81,509 2 payments
  7. RXSIGHT CONTACT LENS $81,509 2 payments
  8. RXSIGHT INJECTOR CARTRIDGE $81,509 2 payments
  9. RXSIGHT INJECTOR HANDPIECE $81,509 2 payments
  10. LIGHT ADJUSTABLE LENS (LAL) $72,466 1 payment
  11. Other $230,723 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

125 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record